4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-004147
Options or other derivatives
- Chief Executive Officer acquired 5,737,704 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rawcliffe Adrian Chief Executive Officer | 2022-01-12 | Grant or award · Option to purchase Ordinary Shares | +4,690,224 | 4,690,224 | D | ||
| Rawcliffe Adrian Chief Executive Officer | 2022-01-12 | Grant or award · Option to purchase Ordinary Shares | +1,047,480 | 1,047,480 | D | ||
Loading xslF345X03/tm221700-5_4seq1.xml…